2015
DOI: 10.1016/j.jns.2015.06.033
|View full text |Cite
|
Sign up to set email alerts
|

Multiple sclerosis and breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 35 publications
0
2
0
Order By: Relevance
“…The etiology of MS is unclear, but it is currently thought to be an immune-mediated demyelinating disease involving the central nervous system ( Mariottini et al, 2022 ; Stampanoni Bassi et al, 2022 ). MS and breast cancer share some common features; most notably, the incidence of both diseases is much higher in women than in men ( O’Malley et al, 2015 ). Numerous studies have explored the relationship between them, but whether MS affects the incidence of breast cancer remains controversial ( Hajiebrahimi et al, 2016 ; Zecca et al, 2021 ; Groome et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…The etiology of MS is unclear, but it is currently thought to be an immune-mediated demyelinating disease involving the central nervous system ( Mariottini et al, 2022 ; Stampanoni Bassi et al, 2022 ). MS and breast cancer share some common features; most notably, the incidence of both diseases is much higher in women than in men ( O’Malley et al, 2015 ). Numerous studies have explored the relationship between them, but whether MS affects the incidence of breast cancer remains controversial ( Hajiebrahimi et al, 2016 ; Zecca et al, 2021 ; Groome et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Again, opposite tendencies are described in the literature for this connection, where the order of appearance of the disease seems to drive the comorbidity pattern. It has been shown that breast cancer patients are 45% less likely to develop multiple sclerosis 51 . On the other hand, multiple sclerosis patients have been shown to have a significantly increased risk of breast cancer, presumably driven by immunosuppression derived from the associated treatment 52 .…”
Section: Discussionmentioning
confidence: 99%